Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Lung Neoplasms 4 Breast Neoplasms 4 Motor Activity 3 Rehabilitation 2 Carcinoma, Non-Small-Cell Lung 2 Sleep Initiation and Maintenance Disorders 1 Sarcoma 1 Pulmonary Disease, Chronic Obstructive 1 Prostatic Neoplasms 1 Pancreatic Diseases 1 Pain, Postoperative 1 Myelodysplastic Syndromes 1 Melanoma 1 Malignant Female Reproductive System Neoplasm 1 Leukemia, Myeloid, Acute 1 Fatigue 1 Dyspnea 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cardiotoxicity 1 Breast Cancer Lymphedema 1 Brain Neoplasms 1 Anaplasia 1 Agnosia 1 Advanced Cancer 1

Interventions

Doxorubicin 15 Exercise 9 Cyclophosphamide 9 Dexrazoxane 8 Razoxane 6 Carvedilol 6 Vincristine 4 Trastuzumab 4 Radiotherapy 4 Filgrastim 4 Docetaxel 4 Methotrexate 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Echocardiography 3 Atorvastatin 3 salicylhydroxamic acid 2 sacubitril and valsartan sodium hydrate drug combination 2 empagliflozin 2 dapagliflozin 2 Tablets 2 Silymarin 2 Prednisone 2 Paclitaxel 2 Neoadjuvant Therapy 2 Leucovorin 2 Ivabradine 2 High-Intensity Interval Training 2 Epirubicin 2 Electrocardiography 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Cardiotoxicity × Rehabilitation × Clear all

NCT06881940 2025-03-18

CARPTOX-BC

Instituto Nacional de Cardiologia Ignacio Chavez

Phase NA Not yet recruiting

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡